Chan, Juliana C. N.

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment

de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 278

Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence

Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 274

Integrated image-based deep learning and language models for primary diabetes care

Li, J., Guan, Z., Wang, J., Cheung, C. Y., Zheng, Y., Lim, L.-L., Lim, C. C., Ruamviboonsuk, P., Raman, R., Corsino, L., et al. (2024) · Nature Medicine

Artificial Intelligence in Healthcare and EducationMachine Learning in Healthcare

Cited by 250

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update

Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 248

Deciphering the “obesity paradox” in the elderly: A systematic review and meta‐analysis of sarcopenic obesity

Liu, C., Wong, P. Y., Chung, Y. L., Chow, S. K., Cheung, W. H., Law, S. W., Chan, J. C. N., & Wong, R. M. Y. (2023) · Obesity Reviews

Nutrition and Health in AgingBody Composition Measurement Techniques

Cited by 247

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

for the ORIENT study investigators, Imai, E., Chan, J. C. N., Ito, S., Yamasaki, T., Kobayashi, F., Haneda, M., & Makino, H. (2011) · Diabetologia

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 236

Association between sleeping hours, working hours and obesity in Hong Kong Chinese: the ‘better health for better Hong Kong’ health promotion campaign

on behalf of the BHBHK Research Committee, T. H. I. O. H. K. H. A., Ko, G. T. C., Chan, J. C. N., Chan, A. W. Y., Wong, P. T. S., Hui, S. S. C., Tong, S. D. Y., Ng, S.-M., Chow, F., & Chan, C. L. W. (2007) · International Journal of Obesity

Sleep and Work-Related FatigueSleep and related disorders

Cited by 176

Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition

Prabhakaran, D., Anand, S., Watkins, D., Gaziano, T., Wu, Y., Mbanya, J. C., Nugent, R., Ajay, V. S., Afshin, A., Adler, A., et al. (2018) · The Lancet

Cardiovascular Health and Risk FactorsGlobal Public Health Policies and Epidemiology

Cited by 162

Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.

Tam, W. H., Ma, R. C. W., Yang, X., Ko, G. T. C., Tong, P. C. Y., Cockram, C. S., Sahota, D. S., Rogers, M. S., & Chan, J. C. N. (2008) · Pediatrics

Gestational Diabetes Research and ManagementBirth, Development, and Health

Cited by 158

Associations of sleep duration with obesity and serum lipid profile in children and adolescents

Kong, A. P., Wing, Y.-K., Choi, K. C., Li, A. M., Ko, G. T. C., Ma, R. C., Tong, P. C., Ho, C.-S., Chan, M. H., Ng, M. H., et al. (2011) · Sleep Medicine

Sleep and related disordersSleep and Wakefulness Research

Cited by 152

Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL trial

Bethel, M. A., Mentz, R. J., Merrill, P., Buse, J. B., Chan, J. C., Goodman, S. G., Iqbal, N., Jakuboniene, N., Katona, B., Lokhnygina, Y., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 112

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Evidence for DNA Damage as a Biological Link Between Diabetes and Cancer

Lee, S. C., & Chan, J. C. (2015) · Chinese Medical Journal

Metabolism, Diabetes, and CancerAdvanced Glycation End Products research

Cited by 106

The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios

McGill, M., Blonde, L., Chan, J. C. N., Khunti, K., Lavalle, F. J., & Bailey, C. J. (2017) · Journal of Clinical & Translational Endocrinology

Diabetes Management and EducationInterprofessional Education and Collaboration

Cited by 95

Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice

Lim, L.-L., Chow, E., & Chan, J. C. N. (2023) · Nature Reviews Endocrinology

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 91

Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data

Magliano, D. J., Chen, L., Carstensen, B., Gregg, E. W., Pavkov, M. E., Salim, A., Andes, L. J., Balicer, R., Baviera, M., Chan, J. C. N., et al. (2022) · The Lancet Diabetes & Endocrinology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 91

Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study

Luk, A. O. Y., Ke, C., Lau, E. S. H., Wu, H., Goggins, W., Ma, R. C. W., Chow, E., Kong, A. P. S., So, W.-Y., & Chan, J. C. N. (2020) · PLOS Medicine

Diabetes and associated disordersDiabetes Management and Research

Cited by 84

Causes of death in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease: insights from the tecos trial

Sharma, A., Green, J. B., Dunning, A., Lokhnygina, Y., Al-Khatib, S. M., Lopes, R. D., Buse, J. B., Lachin, J. M., Van de Werf, F., Armstrong, P. W., et al. (2017) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 80

Increased risk of severe hypoglycemic events before and after cardiovascular outcomes in TECOS suggests an at-risk type 2 diabetes frail patient phenotype

Standl, E., Stevens, S. R., Armstrong, P. W., Buse, J. B., Chan, J. C. N., Green, J. B., Lachin, J. M., Scheen, A., Travert, F., Van de Werf, F., et al. (2018) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 76

Sleep duration and quality, and risk of gestational diabetes mellitus in pregnant Chinese women

Wang, H., Leng, J., Li, W., Wang, L., Zhang, C., Li, W., Liu, H., Zhang, S., Chan, J., Hu, G., et al. (2017) · Diabetic Medicine

Gestational Diabetes Research and ManagementSleep and related disorders

Cited by 75

Anti‐inflammatory effects of exendin‐4, a glucagon‐like peptide‐1 analog, on human peripheral lymphocytes in patients with type 2 diabetes

He, L., Wong, C. K., Cheung, K. K., Yau, H. C., Fu, A., Zhao, H., Leung, K. M., Kong, A. P., Wong, G. W., Chan, P. K., et al. (2013) · Journal of Diabetes Investigation

Diabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases

Cited by 70

Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews

Levis, B., Benedetti, A., Riehm, K. E., Saadat, N., Levis, A. W., Azar, M., Rice, D. B., Chiovitti, M. J., Sanchez, T. A., Cuijpers, P., et al. (2018) · The British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 69

Glucose‐dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose‐dependent insulinotropic peptide receptor‐overexpressing adipocytes

Nie, Y., Ma, R. C., Chan, J. C. N., Xu, H., & Xu, G. (2012) · The FASEB Journal

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 53

Accuracy, precision and user-acceptability of self blood glucose monitoring machines

Chan, J. C. N., Wong, R. Y. M., Cheung, C.-K., Lam, P., Chow, C.-C., Yeung, V. T. F., Kan, E. C. Y., Loo, K.-M., Mong, M. Y. L., & Cockram, C. S. (1997) · Diabetes Research and Clinical Practice

Diabetes Management and ResearchClinical Laboratory Practices and Quality Control

Cited by 52